We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Medtronic Finalizes Covidien Acquisition for USD 50 Billion

By HospiMedica International staff writers
Posted on 01 Feb 2015
Print article
Medtronic (Minneapolis, MN, USA and Dublin, Ireland) completed its acquisition of Covidien (Dublin, Ireland) in lockstep with the Irish High Court’s sanctioning. The companies, both major medical manufacturers of cardiovascular devices, now exist under the name Medtronic plc, with principal executive offices now headquartered in Ireland, which has a much lower corporate tax rate than the US, allowing Medtronic to lower its tax burden. Its operational headquarters remain in Minneapolis and its chairman and CEO, Omar Ishrak, will oversee the company from Minneapolis.

The acquisition allowed the companies to combine a variety of cardiovascular product lines and services, including implantable cardiac therapies such as pacemakers and defibrillators, valves, catheter-based ablation systems, stents, and vascular and peripheral technologies.

The deal is also an opportunity to expand products and services via Covidien’s reach in emerging markets. Covidien employed about 38,000 in more than 70 countries, with 41 manufacturing facilities in 17 countries; Medtronic’s workforce was about 46,000, with 8,000 in Minneapolis. Medtronic plc now totals about 85,000 employees working in 160 countries.

“Through this combination, Medtronic is expected to generate significant free cash flow, which it will be able to deploy with greater strategic flexibility, particularly in the US,” the companies said in a joint statement. Medtronic also plans to use USD 10 billion over a decade in the US to invest in early-stage companies and fund acquisitions.

Medtronic announced in June 2014 that it planned to buy Covidien for USD 43 billion and that it agreed to a cash-and-stock deal. The final transaction totaled almost USD 50 billion. Covidien and Medtronic shares have ceased trading, being replaced by Medtronic plc shares (MDT).

Related Links:


Gold Supplier
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Dose Area Product Measuring System
VacuDAP duo
Digital Ultrasound Scanner
PL-3018I 3D
Hydraulic Surgeon's Chair/Stool

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Surgical Techniques

view channel
Image: The deployable electrodes are ideal for minimally invasive craniosurgery (Photo courtesy of EPFL)

Soft Robotic Electrode Offers Minimally Invasive Solution for Craniosurgery

Minimally invasive medical procedures offer numerous benefits to patients, including decreased tissue damage and shorter recovery periods. However, creating equipment that can pass through a small opening... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.